• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pharmaceutical Pricing: Dynamics in a Global Market Product Image

Pharmaceutical Pricing: Dynamics in a Global Market

  • Published: April 2010
  • Region: Global
  • 20 Pages
  • Business Monitor International

BMI analyses pharmaceutical consumer price indices across 40 countries, identifying historic and likely future trends in pricing policies and dynamics.

Effective pricing strategies have become an evermore crucial tool for the increasingly globalised pharmaceutical industry. Identifying an appropriate entry price and subsequent revisions for patented pharmaceuticals has been vital in ensuring strong uptake and a healthy product life-cycle for many years. Moreover, the competitiveness of the generics sector has resulted in strong pricing pressures throughout the industry.

While market forces and supply and demand theory has a large influence on the price of many commodities, medicines can be considered a special case. In most cases, medicines are viewed as essential goods, with patients generally willing to purchase them up to the point at which they become prohibitively expensive, or a cheaper, yet effective alternative becomes available. From a regulatory point of view, pharmaceutical prices are tightly controlled by the government in many developed states – particularly those where reimbursement is available. This leads to further complications for drug-makers, READ MORE >

Pharmaceutical Pricing: Dynamics In A Global Market
Introduction
Methodology

Global Trends & Development

Global
chart: Largely Below General
Global Pharmaceutical CPI Trends
Developed States Vs Emerging Markets
chart: Less State Support In EMs
Pharmaceutical Spending By Payer Type
chart: Developed Economies = Developed Controls
Pharmaceutical CPI In Developed States & Emerging Markets

United States
chart: Free Pricing Means Mixed Dynamics
US Prescription Drug Consumer Price Index (CPI)
chart: Increases Branded As Shocking
US - Average Annual Percentage Change In Manufacturer Prices For Prescription Drugs

European Union
chart: Accession Peak
EU Harmonised Consumer Price Index (HCPI) For Pharmaceuticals

East Vs West
chart: Further Convergence To Come
Pharmaceutical Products CPI For Older & Newer EU Members

Japan
chart: Massive Pricing Pressures
Japan’s Medicines & Health Fortification CPI

BRIC
chart: Growth Potential At Risk
BRIC Pharmaceutical Market Forecast
Brazil
chart: Generally Fair & Transparent
Brazil’s Pharmaceutical Products Consumer Price Index
Russia
chart: Major Spike
Russia’s Medicine Consumer Price Index
chart: Import Reliance = Forex Vulnerability
Ruble Exchange Rate History
India
chart: Price Environment Clouded By Demographics
India’s Drugs & Medicines Wholesale Price Index
chart: Depreciation Had Some Afect
Rupee Exchange Rate History
China
chart: Western Meds Down, TC Ms Up
China’s Medicine Consumer Price Indices

Summary & Outlook
Overview

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos